Latest Regulatory Compliance News

Acorn Capital Investment Fund Limited has been suspended from ASX trading due to a delayed periodic report, raising questions about its compliance and investor transparency.

Bendigo and Adelaide Bank reported a modest dip in cash earnings for the half year ended December 2024, offset by strong residential lending growth and a maintained fully franked dividend. The bank’s strategic investments and digital transformation efforts continue amid margin compression and rising expenses.

Many Peaks Minerals Limited has amended its previous ASX announcement on auger sampling at the Ferké Gold Project to enhance regulatory compliance, while continuing to advance exploration with diamond drilling and planned air core and RC programs.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.

Global Lithium Resources Limited has refreshed its board following the 2025 AGM, appointing Dr Dianmin Chen as Managing Director and CEO to spearhead strategic milestones at the Manna Lithium Project and restore investor confidence.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

AMP Limited’s 2024 results reveal a 43% drop in statutory net profit to $150 million, offset by a 15.1% rise in underlying profit to $236 million, alongside the completion of its Advice business sale and the launch of a new digital bank.

Pure Foods Tasmania has executed key loan extensions with Commonwealth Bank and outlined a comprehensive turnaround strategy to address its financial challenges, despite ongoing material uncertainty over its going concern status.

Neurotech International has inked a development deal with RH Farma to produce a pharmaceutical-grade cannabinoid drug targeting pediatric neurodevelopmental disorders, leveraging advanced European extraction technology.

ASX Limited has reported a robust first half of FY25 with record operating revenue and a near 10% rise in underlying net profit, underpinned by strong growth across key business segments and a strategic focus on technology modernization.

Gold Mountain Limited has confirmed high-grade Rare Earth Oxide mineralisation from 56 drill holes at its Down Under REE Project in Brazil, highlighting significant potential for resource expansion and further exploration.